SHC · Sotera Health Company
$18.10
-0.17% last session
End-of-day data · close of 2026-10-23
Market cap
$5B
Enterprise value
$7B
Trailing P/E
31.8
Forward P/E
16.8
Dividend yield
0.0%
Beta
1.86
Avg volume
2M
Employees
3K
Daily Change %
-0.17%
5 Days Change
1.34%
10 Days Change
-0.44%
30 Days Change
-0.87%
60 Days Change
-5.43%
Month to Day Change
0.06%
Year to Day Change
2.78%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — SHC
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-14
Latest call per bank · past 12 months
JP Morgan
Underweight$17.00
-6.1% vs priceCitigroup
Buy$25.00
+38.1% vs priceBarclays
Overweight$22.00
+21.5% vs priceGoldman Sachs
Buy$20.00
+10.5% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-14 | JP Morgan | Downgrade | Neutral → Underweight | $0.00 → $17.00 |
| 2026-08-07 | Citigroup | Maintains | Buy | $23.00 → $25.00 |
| 2026-08-07 | Barclays | Maintains | Overweight | $19.00 → $22.00 |
| 2026-08-07 | Piper Sandler | Reiterates | Overweight | $22.00 → $25.00 |
| 2026-08-07 | JP Morgan | Maintains | Neutral | $16.00 → $18.00 |
| 2026-06-24 | Barclays | Maintains | Overweight | $18.00 → $19.00 |
| 2026-06-05 | Goldman Sachs | Initiates | Buy | $0.00 → $20.00 |
| 2026-05-06 | Piper Sandler | Reiterates | Overweight | $24.00 → $22.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-23
- neutral: RSI (14): RSI is 49 — neutral momentum, neither overbought nor oversold.
- bearish: Price vs 50-day MA: Trading 2.5% below the 50-day MA ($18.56).
- bullish: Price vs 200-day MA: Trading 6.3% above the 200-day MA ($17.02).
- bullish: MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- bullish: MACD (12,26,9): MACD histogram is positive (+0.02) — short-term momentum is improving.
- neutral: 52-week range: Price sits between the 52-week low ($13.13) and high ($19.57).
SHC Price Chart
Loading chart for SHC…
Fundamentals
About Sotera Health Company
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
More in Diagnostics & Research
TMO
Thermo Fisher Scientific Inc
$249B 17.1% YTD
DHR
Danaher Corporation
$162B 1.0% YTD
NTRA
Natera, Inc.
$58B 75.2% YTD
A
Agilent Technologies, Inc.
$49B 28.7% YTD
IQV
IQVIA Holdings, Inc.
$46B 23.5% YTD
WAT
Waters Corporation
$45B 20.0% YTD
IDXX
IDEXX Laboratories, Inc.
$44B -16.2% YTD
ILMN
Illumina, Inc.
$41B 105.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.